•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus

  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval

Posted on June 18, 2019June 18, 2019
Posted in Investor News

Post navigation

Miniaturized Inhaled Nitric Oxide Delivery Units for Use in a Doctor’s Office
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2021 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern